BevCanna (CSE: BEV) Chief Commercialization Officer Emma Andrews sat down with Proactive Vancouver’s Steve Darling with news the company has received their research licence with from Health Canada. The newly-granted license allows BevCanna to test cannabinoid infusion equipment on their bottling line, as well as in the lab.
Andrews also telling Proactive about two new lines they have debuted including Deeper Green and Gruv.
CSE:BEV
Market: CSE
Market Cap: $17.41 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Bevcanna Enterprises Inc. named herein, including the promotion by the Company of Bevcanna Enterprises Inc. in any Content on the Site, the...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
Buds & Duds: Cannabis stocks sink as Cronos, Tilray feel the effects of...
The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada slipped 1.1% at 123.9 points. The OTCQX Cannabis Index sank 1.8% at 447.3 points. Buds today were TransCanna Holdings Inc (CSE:TCAN), Nabis Holdings Inc (CSE:NAB) (OTCMKTS:NABIF), BevCanna...
on 11/13/2019
2 min read
Prev article
4 min read
